Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$227K Hold
1,196
0.09% 188
2018
Q4
$233K Sell
1,196
-20
-2% -$3.9K 0.11% 179
2018
Q3
$252K Hold
1,216
0.09% 181
2018
Q2
$224K Hold
1,216
0.08% 199
2018
Q1
$207K Sell
1,216
-98
-7% -$18K 0.08% 197
2017
Q4
$229K Buy
1,314
+9
+0.7% +$1.59K 0.08% 184
2017
Q3
$243K Sell
1,305
-14
-1% -$2.48K 0.09% 173
2017
Q2
$227K Hold
1,319
0.09% 178
2017
Q1
$216K Buy
+1,319
New +$219K 0.09% 176
2016
Q4
Sell
-1,216
Closed -$203K 187
2016
Q3
$203K Buy
+1,216
New +$206K 0.09% 161

Other funds holding AMGN

BKS Advisors's AMGN Position: Q1 2019 in Review

BKS Advisors held its Amgen (AMGN) position steady in Q1 2019 at 1,196 shares worth $227K. The position accounts for 0.09% of the portfolio, ranked #188.

BKS Advisors first reported a position in AMGN in Q3 2016 and has held it in 10 quarters since. The position peaked at $252K in Q3 2018. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • BKS Advisors held 1,196 shares of Amgen worth $227K as of Q1 2019.
  • BKS Advisors left its Amgen share count unchanged in Q1 2019.
  • Amgen made up 0.09% of BKS Advisors's portfolio in Q1 2019, its #188 holding.
  • BKS Advisors first reported a position in Amgen in Q3 2016 and has held it in 10 quarters since.
  • BKS Advisors's Amgen position peaked at $252K in Q3 2018.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.